Diabetics often develop a problem with the nerves that control internal body functions, known as diabetic autonomic neuropathy. Autonomic neuropathy is a common and serious complication of diabetes, one that increases the risk of death. Effective treatments are limited by a lack of any clear understanding of what causes the problem.
Now, European researchers report that so-called self or autoantibodies that attack the body’s own nerve cells are associated with the subsequent development of autonomic neuropathy in diabetic patients.
Among a group of type 1 or insulin-dependent diabetic patients, more than half had autonomic nerve autoantibodies and these patients had a greater than sevenfold increased risk of developing autonomic neuropathy, stated Dr. Viktoria Granber
These observations suggest that autonomic neuropathy in type 1 diabetes may have an autoimmune background, Granberg of Malmo University Hospital in Sweden and colleagues conclude.
Their study is published in this month’s issue of Diabetes Care.

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Top diabetes professor drafts risk assessment document for frontline COVID-19 staff

The health and wellbeing of frontline NHS staff has been prioritised among…

Coronavirus: UK instructed to stay at home this weekend

Health Secretary Matt Hancock has said that staying at home this weekend…

Twice daily dairy intakes could reduce type 2 diabetes risk

Eating cheese, yoghurt or eggs twice a day could help lower the…